Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.

[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].

Grimm J, Müller-Hülsbeck S, Blume J, Biederer J, Heller M.

Rofo. 2001 Mar;173(3):266-72. German.

PMID:
11293872
2.

MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.

Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R.

Eur Radiol. 2000;10(11):1697-702.

PMID:
11097390
3.

Small (<or= 2 cm) hepatic lesions in colorectal cancer patients: detection and characterization on mangafodipir trisodium-enhanced MRI.

Kim KW, Kim AY, Kim TK, Park SH, Kim HJ, Lee YK, Park MS, Ha HK, Kim PN, Kim JC, Lee MG.

AJR Am J Roentgenol. 2004 May;182(5):1233-40.

PMID:
15100125
4.
5.

Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.

Karabacakoğlu A, Adigüzel Y, Karaköse S, Kayaçetin E, Haykir R.

Turk J Gastroenterol. 2006 Sep;17(3):164-71.

6.

Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.

Scharitzer M, Schima W, Schober E, Reimer P, Helmberger TK, Holzknecht N, Stadler A, Ba-Ssalamah A, Weber M, Wrba F.

J Comput Assist Tomogr. 2005 Mar-Apr;29(2):181-90.

PMID:
15772534
7.

Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.

Regge D, Campanella D, Anselmetti GC, Cirillo S, Gallo TM, Muratore A, Capussotti L, Galatola G, Floriani I, Aglietta M.

Clin Radiol. 2006 Apr;61(4):338-47.

PMID:
16546464
8.

Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.

Bartolozzi C, Donati F, Cioni D, Procacci C, Morana G, Chiesa A, Grazioli L, Cittadini G, Cittadini G, Giovagnoni A, Gandini G, Maass J, Lencioni R.

Eur Radiol. 2004 Jan;14(1):14-20. Epub 2003 Aug 9.

PMID:
14730384
9.

[Focal secondary malignant liver lesions: MnDPDP-enhanced MRT at 0.2 tesla vs. helical CT-arterioportography].

Rieger J, Körner M, Linsenmaier U, Rock C, Wirth S, Pfeifer KJ.

Rofo. 2002 Nov;174(11):1402-7. German.

PMID:
12424667
10.

Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.

Burkill GJ, Mannion EM, Healy JC.

Clin Radiol. 2001 Jan;56(1):67-71.

PMID:
11162701
11.

MnDPDP enhanced magnetic resonance imaging of focal liver lesions.

King LJ, Burkill GJ, Scurr ED, Vlavianos P, Murray-Lyons I, Healy JC.

Clin Radiol. 2002 Dec;57(12):1047-57.

PMID:
12475527
12.

Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.

Padovani B, Lecesne R, Raffaelli C, Chevallier P, Drouillard J, Bruneton JN, Lambrechts M, Gordon P.

Eur J Radiol. 1996 Nov;23(3):205-11.

PMID:
9003926
13.

Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement.

Semelka RC, Martin DR, Balci C, Lance T.

J Magn Reson Imaging. 2001 Mar;13(3):397-401.

PMID:
11241813
14.

Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.

Rockall AG, Planche K, Power N, Nowosinska E, Monson JP, Grossman AB, Reznek RH.

Neuroendocrinology. 2009;89(3):288-95. doi: 10.1159/000176207. Epub 2008 Nov 20.

PMID:
19023191
15.

MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.

Helmberger TK, Laubenberger J, Rummeny E, Jung G, Sievers K, Döhring W, Meurer K, Reiser MF.

Eur Radiol. 2002 Jan;12(1):62-70. Epub 2001 Oct 19.

PMID:
11868075
16.

Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.

Oudkerk M, Torres CG, Song B, König M, Grimm J, Fernandez-Cuadrado J, Op de Beeck B, Marquardt M, van Dijk P, de Groot JC.

Radiology. 2002 May;223(2):517-24.

PMID:
11997562
17.

[Comparative diagnostic value of computed tomography and contrast-enhanced ultrasonography in diagnosis of focal liver lesions].

Zviniene K, Zaboriene I, Basevicius A, Pundzius J.

Medicina (Kaunas). 2009;45(10):751-63. Lithuanian.

18.

[Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].

Jung G, Poll L, Cohnen M, Saleh A, Vogler H, Wettstein M, Willers R, Mödder U, Koch JA.

Rofo. 2005 Nov;177(11):1571-7. German.

PMID:
16302139
19.
20.

Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings.

Birnbaum BA, Weinreb JC, Fernandez MP, Brown JJ, Rofsky NM, Young SW.

Clin Imaging. 1994 Jan-Mar;18(1):21-7.

PMID:
8180855

Supplemental Content

Support Center